|
| 37865323 | Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006-2013. | Environ Res | 2024 |
| 36726302 | Seasonality of main childhood embryonal tumours and rhabdomyosarcoma, France, 2000-2015. | Cancer Med | 2023 |
| 37857712 | AcSé-ESMART, a European precision cancer medicine proof-of-concept platform trial. | Nat Med | 2023 |
| 37574821 | Phase II study of <sup>131</sup> I-metaiodobenzylguanidine with 5Â days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP. | Pediatr Blood Cancer | 2023 |
| 37730754 | Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse. | NPJ Precis Oncol | 2023 |
| 37723198 | A biobank of pediatric patient-derived-xenograft models in cancer precision medicine trial MAPPYACTS for relapsed and refractory tumors. | Commun Biol | 2023 |
| 37444642 | Cell-Free DNA Extracted from CSF for the Molecular Diagnosis of Pediatric Embryonal Brain Tumors. | Cancers (Basel) | 2023 |
| 37012551 | Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results. | Nat Med | 2023 |
| 37142597 | Reversible transitions between noradrenergic and mesenchymal tumor identities define cell plasticity in neuroblastoma. | Nat Commun | 2023 |
| 37434345 | Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis. | Expert Rev Anticancer Ther | 2023 |
| 36916786 | Neuroblastoma with neonatal cardiogenic shock and multiple-organ failure: A rare association. | Pediatr Blood Cancer | 2023 |
| 36602782 | Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models. | Clin Cancer Res | 2023 |
| 34794856 | The feasibility of using liquid biopsies as a complementary assay for copy number aberration profiling in routinely collected paediatric cancer patient samples. | Eur J Cancer | 2022 |
| 36265118 | Molecular Characterization of Circulating Tumor DNA in Pediatric Rhabdomyosarcoma: A Feasibility Study. | JCO Precis Oncol | 2022 |
| 36054452 | Single-cell transcriptomics reveals shared immunosuppressive landscapes of mouse and human neuroblastoma. | J Immunother Cancer | 2022 |
| 36011005 | Suprarenal Masses in Very Young Infants: Is It Safe to Watch and Wait? Report of a SIOPEN Observational Study Results. | Cancers (Basel) | 2022 |
| 35174661 | Intra- and extra-cranial BCOR-ITD tumours are separate entities within the BCOR-rearranged family. | J Pathol Clin Res | 2022 |
| 35292802 | The European MAPPYACTS Trial: Precision Medicine Program in Pediatric and Adolescent Patients with Recurrent Malignancies. | Cancer Discov | 2022 |
| 32662719 | Minimally invasive classification of paediatric solid tumours using reduced representation bisulphite sequencing of cell-free DNA: a proof-of-principle study. | Epigenetics | 2021 |
| 33918978 | A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma. | Cancers (Basel) | 2021 |
| 34994601 | <i>NTRK</i> Alterations in Pediatric High-Risk Malignancies Identified Through European Clinical Sequencing Programs Constitute Promising Drug Targets. | JCO Precis Oncol | 2021 |
| 34543871 | First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial. | Eur J Cancer | 2021 |
| 34656762 | Highly Sensitive Detection Method of Retinoblastoma Genetic Predisposition and Biomarkers. | J Mol Diagn | 2021 |
| 34536944 | Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration. | Eur J Cancer | 2021 |
| 34298378 | Molecular diagnosis of retinoblastoma by circulating tumor DNA analysis. | Eur J Cancer | 2021 |
| 34152804 | Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma: HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study. | J Clin Oncol | 2021 |
| 34115544 | Frequency and Prognostic Impact of <i>ALK</i> Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). | J Clin Oncol | 2021 |
| 33949344 | Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings. | Am J Surg Pathol | 2021 |
| 34050156 | Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden. | Nat Commun | 2021 |
| 33146894 | Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience. | Cancer | 2021 |
| 29409315 | Prognostic impact of postoperative 123I-metaiodobenzylguanidine scintigraphy: added value of SPECT/CT and semiquantification of the uptake at the surgical site. | Q J Nucl Med Mol Imaging | 2020 |
| 31897843 | The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: a review. | Eur J Pediatr | 2020 |
| 32573700 | IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma. | Blood | 2020 |
| 32653773 | Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma. | Eur J Cancer | 2020 |
| 32931402 | Reply to K. Beiske et al. | J Clin Oncol | 2020 |
| 32903140 | Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable <i>MYCN</i>-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group. | J Clin Oncol | 2020 |
| 32642766 | Data Resource Profile: The French Childhood Cancer Observation Platform (CCOP). | Int J Epidemiol | 2020 |
| 32447561 | Correction to: The pitfalls and promise of liquid biopsies for diagnosing and treating solid tumors in children: as review. | Eur J Pediatr | 2020 |
| 32155583 | Infant cancers in France: Incidence and survival (2000-2014). | Cancer Epidemiol | 2020 |
| 32248272 | From Wilms to kidney tumors: which ones require a biopsy? | Pediatr Radiol | 2020 |
| 32247207 | Environmental exposures related to parental habits in the perinatal period and the risk of Wilms' tumor in children. | Cancer Epidemiol | 2020 |
| 32144681 | Maternal and perinatal characteristics, congenital malformations and the risk of wilms tumor: the ESTELLE study. | Cancer Causes Control | 2020 |
| 32315273 | Age, Diagnostic Category, Tumor Grade, and Mitosis-Karyorrhexis Index Are Independently Prognostic in Neuroblastoma: An INRG Project. | J Clin Oncol | 2020 |
| 30697705 | Parental smoking, maternal alcohol consumption during pregnancy and the risk of neuroblastoma in children. A pooled analysis of the ESCALE and ESTELLE French studies. | Int J Cancer | 2019 |
| 35100701 | Efficacy of Lorlatinib in Primary Crizotinib-Resistant Adult Neuroblastoma Harboring <i>ALK</i> Y1278S Mutation. | JCO Precis Oncol | 2019 |
| 29923174 | Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis. | Int J Cancer | 2019 |
| 31300807 | Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours. | Nat Rev Cancer | 2019 |
| 31575060 | Exosomal microRNAs from Longitudinal Liquid Biopsies for the Prediction of Response to Induction Chemotherapy in High-Risk Neuroblastoma Patients: A Proof of Concept SIOPEN Study. | Cancers (Basel) | 2019 |
| 31452835 | ALK mutation dynamics and clonal evolution in a neuroblastoma model exhibiting two ALK mutations. | Oncotarget | 2019 |
| 31309712 | Metastatic neuroblastoma in a patient with ROHHAD: A new alert regarding the risk of aggressive malignancies in this rare condition. | Pediatr Blood Cancer | 2019 |